HomeNEUP • NASDAQ
add
Neuphoria Therapeutics Inc
Previous close
$4.36
Day range
$4.39 - $4.60
Year range
$2.91 - $21.40
Market cap
24.31M USD
Avg Volume
3.23M
P/E ratio
7.00
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.65M | 58.44% |
Net income | -9.91M | -1,130.95% |
Net profit margin | — | — |
Earnings per share | -4.41 | — |
EBITDA | -5.49M | -61.28% |
Effective tax rate | 0.35% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 13.65M | 68.88% |
Total assets | 27.34M | 19.32% |
Total liabilities | 14.83M | 153.70% |
Total equity | 12.51M | — |
Shares outstanding | 5.38M | — |
Price to book | 0.82 | — |
Return on assets | -50.53% | — |
Return on capital | -88.93% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -9.91M | -1,130.95% |
Cash from operations | -3.79M | 14.40% |
Cash from investing | — | — |
Cash from financing | 3.25M | 1,531.18% |
Net change in cash | -560.49K | 87.61% |
Free cash flow | -1.79M | 41.20% |
About
Founded
1996
Headquarters
Website
Employees
8
